Absence of ATM truncations in patients with severe acute radiation reactions

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 5, 1998, Pages 1021-1027

  Clarke, Raymond A ^a   Goozee, Gary R ^a   Birrell, Geoff ^b   Ming Fang, Zhi ^a   Hasnain, Homa ^a   Lavin, Martin ^b   Kearsley, John H ^a  

^a ST GEORGE HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

ATM; Cell proliferation; Chromosomal aberration; P53; Radiosensitivity

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; IONIZING RADIATION; LYMPHOBLASTOID CELL; MALE; PRIORITY JOURNAL; RADIATION SICKNESS; RADIOSENSITIVITY;

ADULT; AGED; CELL CYCLE PROTEINS; CELL LINE; CHROMOSOME ABERRATIONS; DNA-BINDING PROTEINS; FEMALE; G2 PHASE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0032528216     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00171-0     Document Type: Article

References (29)

1. Chen P.C., Lavin M.F., Kidson C., Moss D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature. 274:1978;484-486.
2. 2 chromatid radiosensitivity in dyskeratosis congenita fibroblasts. Am. J. Hum. Genet. 46:1990;350-357.
3. Parshad R., Sanford K.K., Kraemer K.H., Jones G.M., Tarone R.E. Carrier detection in xeroderma pigmentosum. J. Clin Invest. 85:1990;135-138.
4. 2 chromatid radiation damage in familial dysplastic naevus syndrome. Lancet. 2:1987;1111-1116.
5. Paterson M.C., Anderson S.K., Smith B.P., Smith P.J. Enhanced radiosensitivity of cultured fibroblasts from ataxia-telangiectasia heterozygotes manifested by defective colony forming ability and reduced DNA repair replication after hypoxic-irradiation. Cancer Res. 38:1979;3225-3234.
6. 2 phase x-irradiation, a marker of the ataxia-telangiectasia gene. J. Natl. Cancer Inst. 82:1990;1050-1054.
7. Shiloh Y., Parshad R., Sanford K.K., Jones G.M. Carrier detection in ataxia-telangiectasia. Lancet. 1:1986;689-690.
8. Birrell G.W., Ramsay J.R. Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia telangiectasia patients. Br. J. Cancer. 72:1995;1096-1101.
9. Canman C.E., Gilmer T., Coutts S., Kastan M.B. Growth factor modulation of p53-mediated growth arrest vs. apoptosis. Genes Dev. 9:1995;600-611.
10. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.). 362:1993;849-852.
11. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
12. Kastan M.B., Zhan Q., El-Diery W.S., Carrier F., Jack S.T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace J.R. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
13. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:1992;7491-7495.
14. Yonish-Rouach E., Tesnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis in mouse thymocytes. Nature (Lond.). 362:1993;847-849.
15. Athma P., Rappaport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92:1996;130-134.
16. Fitzgerald M.G., Bean J.M., Hedge S.R., Unsal H., Macdonald D.J., Harkin D.P., Finkelstein D.M., Isselbacher K.J., Haber D.A. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet. 15:(3):1997;307-310.
17. Swift M., Chase C.L., Morrell D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet. Cytogenet. 46:1990;21-27.
18. Neitzel H. A routine method for the establishment of permanent growth lymphoblastoid cell lines. Hum. Genet. 73:1986;320-326.
19. 2 phase delay in ataxia-telangiectasia heterozygotes. Cancer Genet. Cytogenet. 60:1992;183-187.
20. Carmichael J., Degraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay Assessment of radiosensitivity . Cancer Res. 47:1987;943-946.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival Application to proliferation and cytotoxicity assays . J. Immunol. Methods. 65:1983;55-63.
22. Price P., McMillan T.J. Use of tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res. 50:1990;1392-1396.
23. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R. Tetrazolium-based assays for cellular viability A critical examination of selected parameters affecting formazan production . Cancer Res. 51:1991;2515-2520.
24. Khanna K.K., Lavin M.F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene. 8:1993;3307-3312.
25. Roest P.A.M., Roberts R.G., Sugino S., Ommen G.-J.B., Dunnen J.T. Protein truncation test (PTT) for rapid detection of translation-termination mutations. Hum. Mol. Genet. 2:(10):1993;1719-1721.
26. Kidson C., Chen P., Imray F.M. Ataxia-telangiectasia heterozygotes Dominant expression of ionizing radiation sensitive mutants . Bridges B.A., Harnden D.G. Ataxia-telangiectasia A cellular and molecular link between cancer, neuropathology and immune deficiency . 1982;363-372 John Wiley, Chichester.
27. Elyan S.A.G., West C.M.L., Roberts S.A., Hunter R.D. Use of an internal standard in comparative measurements of the intrinsic radiosensitivities of human T-lymphocytes. Int. J. Radiat. Biol. 64:(4):1993;385-391.
28. Ramsay J.R., Birrell G.W. In vitro radiosensitivity of lymphoblastoid cell lines from breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;339-344.
29. Watters D., Khanna K.K., Beamish H., Birrell G., Spring K., Kedar P., Gatei M., Stenzel D., Hobson K., Kozlov S., Zhang N., Farrell A., Ramsay J., Gatti R., Lavin M. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene. 14:1997;1911-1921.